HONG KONG, October 7, 2021 / PRNewswire / – Endurance RP Limited’s (“Endurance Longevity” or the “Company” and with its subsidiaries, the “Group”; action code: 0575.HK) ‘s Deep Longevity, Inc, a company acquired on December 14, 2020 which develops artificial intelligence to track human aging and extend productive longevity, is pleased to announce that the very first online course, very popular and now also accredited by the CME, titled “An Introduction to Longevity Medicine for Physicians”, developed in collaboration between leading AI specialists and geoscientists, and medical practitioners to provide the premier credible source of longevity medicine training to improve the skills of health professionals, was recently launched on the UK health data research Platform.
Initiated and written by the interdisciplinary team directed by Alex Zhavoronkov, PhD, from Deep Longevity, Evelyne Bischof, MD, of the University of Zurich International Center for Multimorbidity and Complexity in Medicine (ICMC) and Human Longevity Inc San Diego /Beijing, Alexey Moskalev, PhD, of the Russian Academy of Sciences and Morten Scheibye-Knudsen, MD, PhD, from the University of copenhagen, the free Longevity Medicine Course launched on a public educational platform in December 2020, with over 2,700 learners signing up immediately. In July 2021 the course went to Degree of longevity platform and has received continuing medical education (CME accreditation from the Medical Society of Delaware (MSD). In March 2021, the authors of the Longevity Medicine course worked with the management of Health Data Research UK and the course was adapted and launched on the HDR UK platform. This is a major step towards training a new generation of longevity physicians in the UK and beyond.
âI was delighted to be able to help bring the very popular ‘Introduction to Longevity Medicines for Physicians’ to the learning sector in the UK.,” noted Alain davis, Director of Innovative Programs and Partnerships Innovation, Digital & Transformation Department at NHS Health education in England. “The work of Alexis, Evelyne and my colleagues is truly revolutionary, and I have long been fascinated by the amount of information that can be inferred and the potential for lifespan change that can arise from new biomarkers and the implementation of AI that is associated with them. It is a course very attentive to the future needs of society. ”
Longevity medicine is defined as a branch of precision medicine that specifically focuses on the promotion of lifespan and health, and is powered by AI technology. (Zhavoronkov, A., Bischof, E. & Lee, KF. Artificial intelligence in longevity medicine. Nat 1, 5-7 years (2021). https://doi.org/10.1038/s43587-020-00020-4). It is a rapidly growing, rapidly evolving discipline fueled by advances in gerosciences, AI / biotech and clinical medicine. In addition, it is continuously adding the most advanced personalized approaches, such as multi-omics, deep aging biomarkers, precision imaging, deep aging clocks, robotics, smart technologies, and more. This enormous pace and granularity requires intensive acceleration of translation from basic science to clinical practice, as well as credible parallel and continuing education for practicing physicians.
The goal of longevity medicine is to use new quantifiable and quantifying biomarkers of aging, for example deep aging clocks, with the aim of keeping the biological and psychological age of the patient as close as possible to the age. optimum performance state throughout life.
The Longevity Medicine Course group has published two consecutive scientific papers to define this new area of âânatural aging, “Artificial intelligence in longevity medicine“and in Lancet Healthy Longevity,”Longevity medicine: training the doctors of tomorrowThe course also extends to various leading national educational platforms, in the respective local languages, including China, Switzerland, France, Israel, Brazil, Russia etc. At the same time, the course is continuously updated. More importantly, however, a large new area of ââcoursework is set to launch very soon, including a 12-hour course for scientists and advanced practitioners in longevity medicine, as well as a separate course designed specifically for clinicians, based on real world and demonstrative case studies. .
Clinical and scientific authors Team critically assesses the educational and scientific outcomes of the first cohort of learners, in order to develop new learning tools and practical guidelines for the field of longevity medicine. Course organizers are also looking at how physicians use the learned course material in their day-to-day work as well as in their follow-up training choices. The results and new learning tools were presented to the Longevity medicine Wworkshop to 8th research on aging for drugs Discovery conference.
“Physicians are the essential part of the longevity industry and it can only evolve as fast as physicians. Therefore, keeping physicians informed of recent advances in research on aging is extremely important and is equally important. to keep them engaged. This course provides a very basic introduction to the field of longevity medicine where instead of treating or preventing disease we try to keep the patient as close as possible to the state of peak performance. of the service life as long as possible,” Alex Zhavoronkov, PhD, course co-founder.
“We are delighted that more and more international medical platforms are adopting the longevity medicine course. It is a crucial and self-explanatory task to disseminate the knowledge of longevity medicine in a specially prepared course. and targeted for physicians with the intention of arousing their enthusiasm towards this news, hopefully, soon defined as a subspecialty or a discipline. Our will and our motivation are to create a bridge between gerosciences and clinical medicine “, Evelyne Bischof, MD, Longevity Physician at Human Longevity and Professor of Clinical Medicine at the Shanghai University of Medicine and Health Sciences.
âThe acceleration of developments in longevity science and the growth of practical solutions to keep us healthier longer as we age is exciting for clinicians and all healthcare professionals interested in 4P (predictive medicine) medicine. , preventive, personalized, participatory). This course provides an excellent foundation for applying this knowledge in daily work in the quest for equitable healthy longevity for all citizens., “ Tina Woods, CEO, Collider Health, Director, APPG for Longevity.
“We are delighted to host Deep Longevity’s Accredited Longevity Medicine on HDR UK Futures. This is just one of many high quality accredited learning programs that HDR UK is proud to host on our cutting-edge learning platform., “ Sarah Cadman, Program Director – Talent & Training HDR UK.
About deep longevity
Deep Longevity was acquired by Endurance Longevity (SEHK: 0575.HK), a publicly traded company. Deep Longevity develops explainable artificial intelligence systems to track the rate of aging at the molecular, cellular, tissue, organic, systemic, physiological and psychological levels. He is also developing systems for the emerging field of longevity medicine that allow physicians to make better decisions about interventions that may slow or reverse aging processes. Deep Longevity has developed the Longevity as a Service (LaaS) Â© solution to integrate several deep aging biomarkers called âdeep aging clocksâ to provide a universal multifactor measure of human biological age. Originally incubated by Insilico Medicine, Deep Longevity began its independent journey in 2020 after securing funding from the most credible venture capitalists specializing in biotechnology, longevity and artificial intelligence. ETP Ventures, Human Longevity and Performance Impact Venture Fund, BOLD Capital Partners, Longevity Vision Fund, LongeVC, co-founder of Oculus, Michael Antonov, and other investors with expertise in AI and biotechnology have supported the company. Deep Longevity has established a research partnership with one of the world’s premier longevity organizations, Human Longevity, Inc. to provide a range of aging clocks to the network of advanced physicians and researchers..
About endurance longevity (Stock code: 0575.HK)
Endurance Longevity is a diversified investment group based in Hong Kong currently holds various corporate and strategic investments focused on the health, wellness and life sciences sectors. The Group has a solid investment history and has reported around $ 298 million to shareholders over the 21 years of financial reporting since its initial public offering.
HDR is designed to provide advanced training for physicians in the UK and around the world. Its mission is to unite UK healthcare and care data to enable discoveries that improve people’s lives. To do this, we unite, improve and use data on health and care in a single national institute.
Copyright Â© acrofan All rights reserved